Access to pain treatment a luxury for most
Joseph Amon, Diederik Lohman, Laura Thomas
20091001
2009 Nov 1
Lancet
Yes
Access to pain treatment a luxury for most
Lancet. 374(9702)1676, Joseph Amon, Diederik Lohman, Laura Thomas
Guy Micco and colleagues (Sept 12, p 872)1 are right to emphasise that, whenever possible, patients near the end of their lives must be free to choose whether their care includes optimum pain relief, or more limited use of opioids with the aim of promoting consciousness and lucidity. However, for most patients worldwide, there is no such choice.WHO estimates that each year 5·5 million patients with terminal cancer and 1 million with end-stage HIV/AIDS die without access to adequate pain treatment.2...